Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

Theresa Kissel; Tineke J. van Wesemael; Anders Lundquist; Heidi Kokkonen; Atsushi Kawakami; Mami Tamai; Dirkjan van Schaardenburg; Manfred Wuhrer; Tom W. J. Huizinga; Hans Ulrich Scherer; Diane van der Woude; Solbritt Rantapää-Dahlqvist; René E. M. Toes

doi:https://doi.org/10.1136/annrheumdis-2021-220841

Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

Theresa Kissel, Tineke J. van Wesemael, Anders Lundquist, Heidi Kokkonen, Atsushi Kawakami, Mami Tamai, Dirkjan van Schaardenburg, Manfred Wuhrer, Tom W. J. Huizinga, Hans Ulrich Scherer, Diane van der Woude, Solbritt Rantapää-Dahlqvist, René E. M. Toes

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Citations (Scopus)

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Annals of the rheumatic diseases
Volume	16
DOIs	https://doi.org/10.1136/annrheumdis-2021-220841
Publication status	Published - 12 Aug 2021

Keywords

anti-citrullinated protein antibodies
arthritis
autoimmune diseases
rheumatoid

Access to Document

https://doi.org/10.1136/annrheumdis-2021-220841

Cite this

Kissel, T., van Wesemael, T. J., Lundquist, A., Kokkonen, H., Kawakami, A., Tamai, M., van Schaardenburg, D., Wuhrer, M., Huizinga, T. W. J., Scherer, H. U., van der Woude, D., Rantapää-Dahlqvist, S., & Toes, R. E. M. (2021). Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA. Annals of the rheumatic diseases, 16, 1-3. https://doi.org/10.1136/annrheumdis-2021-220841

@article{3a4c0cfe09a04196afcad85e0b69dc18,

title = "Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA",

keywords = "anti-citrullinated protein antibodies, arthritis, autoimmune diseases, rheumatoid",

author = "Theresa Kissel and {van Wesemael}, {Tineke J.} and Anders Lundquist and Heidi Kokkonen and Atsushi Kawakami and Mami Tamai and {van Schaardenburg}, Dirkjan and Manfred Wuhrer and Huizinga, {Tom W. J.} and Scherer, {Hans Ulrich} and {van der Woude}, Diane and Solbritt Rantap{\"a}{\"a}-Dahlqvist and Toes, {Ren{\'e} E. M.}",

note = "Funding Information: Funding This work has been financially supported by ReumaNederland (17-1-402 and 08-1-34), the IMI funded project RTCure (777357), ZonMw TOP (91214031) and by Target to B! (LSHM18055-5GF). REMT is a recipient of a European Research Council advanced grant (AdG2019-884796). The work has been further funded by the Swedish Research Council (VR Dnr: 2018–02551), the King Gustaf V{\textquoteright}s 80 Year Fund, the King Gustaf V{\textquoteright}s and Queen Victoria{\textquoteright}s Fund and the Swedish Rheumatism Association. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = aug,

day = "12",

doi = "https://doi.org/10.1136/annrheumdis-2021-220841",

language = "English",

volume = "16",

pages = "1--3",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

Kissel, T, van Wesemael, TJ, Lundquist, A, Kokkonen, H, Kawakami, A, Tamai, M, van Schaardenburg, D, Wuhrer, M, Huizinga, TWJ, Scherer, HU, van der Woude, D, Rantapää-Dahlqvist, S & Toes, REM 2021, 'Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA', Annals of the rheumatic diseases, vol. 16, pp. 1-3. https://doi.org/10.1136/annrheumdis-2021-220841

TY - JOUR

T1 - Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

AU - Kissel, Theresa

AU - van Wesemael, Tineke J.

AU - Lundquist, Anders

AU - Kokkonen, Heidi

AU - Kawakami, Atsushi

AU - Tamai, Mami

AU - van Schaardenburg, Dirkjan

AU - Wuhrer, Manfred

AU - Huizinga, Tom W. J.

AU - Scherer, Hans Ulrich

AU - van der Woude, Diane

AU - Rantapää-Dahlqvist, Solbritt

AU - Toes, René E. M.

N1 - Funding Information: Funding This work has been financially supported by ReumaNederland (17-1-402 and 08-1-34), the IMI funded project RTCure (777357), ZonMw TOP (91214031) and by Target to B! (LSHM18055-5GF). REMT is a recipient of a European Research Council advanced grant (AdG2019-884796). The work has been further funded by the Swedish Research Council (VR Dnr: 2018–02551), the King Gustaf V’s 80 Year Fund, the King Gustaf V’s and Queen Victoria’s Fund and the Swedish Rheumatism Association. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/8/12

Y1 - 2021/8/12

KW - anti-citrullinated protein antibodies

KW - arthritis

KW - autoimmune diseases

KW - rheumatoid

UR - http://www.scopus.com/inward/record.url?scp=85113169902&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/annrheumdis-2021-220841

DO - https://doi.org/10.1136/annrheumdis-2021-220841

M3 - Comment/Letter to the editor

C2 - 34385139

SN - 0003-4967

VL - 16

SP - 1

EP - 3

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -

Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA

Keywords

Access to Document

Other files and links

Cite this